United States Biotechnology & Medical Research

enVVeno Medical Corp (NVNO)

Track

Track

Over the past ninety days, enVVeno Medical Corp recorded two insider trading transactions involving Director Francis Duhay. These activities consisted exclusively of planned sales totaling approximately 2,886 dollars. This selling pattern follows a period where the firm reported a negative earnings report, while the stock price experienced a modest increase of nearly fourteen percent recently.
Ticker: NVNO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for enVVeno Medical Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Duhay Francis Non-Executive Director
Transaction date
Planned sale
Price
183.52
Quantity 78,748 +41.9%
Value US$836,933
2.2
Duhay Francis Director Non-Executive Director
Transaction date
Proposed sale
Price
188.96
Quantity 83,069
Value US$4,644,415
2.2
Duhay Francis Non-Executive Director
Transaction date
Planned sale
Price
370.90
Quantity 62,018 -38.4%
Value US$4,573,040
2.2
Duhay Francis Director Non-Executive Director
Transaction date
Proposed sale
Price
11.52
Quantity 140
Value US$1,613
2.2
Duhay Francis Non-Executive Director
Transaction date
Planned sale
Price
0.36
Quantity 4,900 -5.0%
Value US$1,742
2.2
Duhay Francis Non-Executive Director
Transaction date
Planned sale
Price
0.83
Quantity 4,900 -4.8%
Value US$4,067
2.2
Duhay Francis Director Non-Executive Director
Transaction date
Proposed sale
Price
0.83
Quantity 9,800
Value US$8,143
2.2
Duhay Francis Non-Executive Director
Transaction date
Purchase
Price
3.07
Quantity 81,433 +389.4%
Value US$249,999
3.1
Gray Robert Non-Executive Director
Transaction date
Purchase
Price
2.94
Quantity 3,500 +45.7%
Value US$10,290
3.3
Shrivastava Sanjay Non-Executive Director
Transaction date
Purchase
Price
2.90
Quantity 5,400 +138.9%
Value US$15,660
2.5
Jenusaitis Matthew Non-Executive Director
Transaction date
Purchase
Price
2.53
Quantity 9,620 +138.9%
Value US$24,339
3.3
BERMAN ROBERT ANDREW Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.55
Quantity 12,000 +5.7%
Value US$30,600
3.1
Alavi Hamed Chief Technology Officer Officer
Transaction date
Sale
Price
6.22
Quantity 8,334 -100.0%
Value US$51,837
2.2
Duhay Francis Non-Executive Director
Transaction date
Purchase
Price
6.14
Quantity 7,751 +58.9%
Value US$47,591
3.3
Shrivastava Sanjay Non-Executive Director
Transaction date
Purchase
Price
3.85
Quantity 1,000 +34.6%
Value US$3,850
3.3
BERMAN ROBERT ANDREW Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.80
Quantity 2,500 +1.2%
Value US$9,500
3.3
BERMAN ROBERT ANDREW CEO Executive Director
Transaction date
Purchase
Price
7.43
Quantity 2,000 +34.9%
Value US$14,860
3.3
BERMAN ROBERT ANDREW CEO Officer
Transaction date
Purchase
Price
7.87
Quantity 2,000 +53.5%
Value US$15,740
3.1
Gray Robert Non-Executive Director
Transaction date
Purchase
Price
6.25
Quantity 2,000 +56.0%
Value US$12,500
3.0
Glickman Marc H. SVP & Chief Medical Officer Officer
Transaction date
Purchase
Price
5.90
Quantity 1,600 +inf%
Value US$9,440
3.3
BERMAN ROBERT ANDREW Chief Executive Officer Executive Director
Transaction date
Purchase
Price
5.47
Quantity 3,000 +407.6%
Value US$16,410
3.1
Biodyne Holding, S.A. Large shareholder
Transaction date
Sale
Price
0.31
Quantity 1,683 -0.1%
Value US$522
3.1
Biodyne Holding, S.A. Large shareholder
Transaction date
Sale
Price
0.31
Quantity 3,900 -0.1%
Value US$1,209
3.1
Biodyne Holding, S.A. Large shareholder
Transaction date
Sale
Price
0.33
Quantity 220,000 -6.1%
Value US$72,600
3.1
Biodyne Holding, S.A. Large shareholder
Transaction date
Sale
Price
0.67
Quantity 684,813 -16.1%
Value US$458,825
3.3
BERMAN ROBERT ANDREW Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.15
Quantity 21,740 +inf%
Value US$25,001
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-12 2026-06-11 PlS Planned sale
2.2
Duhay Francis
Non-Executive Director
78,748 +41.9%
183.52
US$836,933 		78,748 +41.9% 183.52 US$836,933
2026-06-11 2026-06-11 PrS Proposed sale
2.2
Duhay Francis

Director

Non-Executive Director
83,069
188.96
US$4,644,415 		83,069 188.96 US$4,644,415
2026-03-13 2026-03-12 PlS Planned sale
2.2
Duhay Francis
Non-Executive Director
62,018 -38.4%
370.90
US$4,573,040 		62,018 -38.4% 370.90 US$4,573,040
2026-03-12 2026-03-12 PrS Proposed sale
2.2
Duhay Francis

Director

Non-Executive Director
140
11.52
US$1,613 		140 11.52 US$1,613
2025-12-12 2025-12-11 PlS Planned sale
2.2
Duhay Francis
Non-Executive Director
4,900 -5.0%
0.36
US$1,742 		4,900 -5.0% 0.36 US$1,742
2025-09-17 2025-09-15 PlS Planned sale
2.2
Duhay Francis
Non-Executive Director
4,900 -4.8%
0.83
US$4,067 		4,900 -4.8% 0.83 US$4,067
2025-09-15 2025-09-15 PrS Proposed sale
2.2
Duhay Francis

Director

Non-Executive Director
9,800
0.83
US$8,143 		9,800 0.83 US$8,143
2025-01-03 2024-12-31 B Purchase
2.2
Duhay Francis
Non-Executive Director
81,433 +389.4%
3.07
US$249,999 		81,433 +389.4% 3.07 US$249,999
2025-01-02 2024-12-31 B Purchase
3.1
Gray Robert
Non-Executive Director
3,500 +45.7%
2.94
US$10,290 		3,500 +45.7% 2.94 US$10,290
2024-12-26 2024-12-24 B Purchase
3.3
Shrivastava Sanjay
Non-Executive Director
5,400 +138.9%
2.90
US$15,660 		5,400 +138.9% 2.90 US$15,660
2024-12-23 2024-12-19 B Purchase
2.5
Jenusaitis Matthew
Non-Executive Director
9,620 +138.9%
2.53
US$24,339 		9,620 +138.9% 2.53 US$24,339
2024-12-19 2024-12-19 B Purchase
3.3
BERMAN ROBERT ANDREW

Chief Executive Officer

Executive Director
12,000 +5.7%
2.55
US$30,600 		12,000 +5.7% 2.55 US$30,600
2024-03-15 2024-03-13 S Sale
3.1
Alavi Hamed

Chief Technology Officer

Officer
8,334 -100.0%
6.22
US$51,837 		8,334 -100.0% 6.22 US$51,837
2022-08-18 2022-08-16 B Purchase
2.2
Duhay Francis
Non-Executive Director
7,751 +58.9%
6.14
US$47,591 		7,751 +58.9% 6.14 US$47,591
2022-07-01 2022-06-30 B Purchase
3.3
Shrivastava Sanjay
Non-Executive Director
1,000 +34.6%
3.85
US$3,850 		1,000 +34.6% 3.85 US$3,850
2022-06-28 2022-06-27 B Purchase
3.3
BERMAN ROBERT ANDREW

Chief Executive Officer

Executive Director
2,500 +1.2%
3.80
US$9,500 		2,500 +1.2% 3.80 US$9,500
2021-11-19 2021-11-19 B Purchase
3.3
BERMAN ROBERT ANDREW

CEO

Executive Director
2,000 +34.9%
7.43
US$14,860 		2,000 +34.9% 7.43 US$14,860
2021-11-18 2021-11-16 B Purchase
3.3
BERMAN ROBERT ANDREW

CEO

Officer
2,000 +53.5%
7.87
US$15,740 		2,000 +53.5% 7.87 US$15,740
2021-06-21 2021-06-16 B Purchase
3.1
Gray Robert
Non-Executive Director
2,000 +56.0%
6.25
US$12,500 		2,000 +56.0% 6.25 US$12,500
2021-05-25 2021-05-21 B Purchase
3.0
Glickman Marc H.

SVP & Chief Medical Officer

Officer
1,600 +inf%
5.90
US$9,440 		1,600 +inf% 5.90 US$9,440
2021-05-19 2021-05-18 B Purchase
3.3
BERMAN ROBERT ANDREW

Chief Executive Officer

Executive Director
3,000 +407.6%
5.47
US$16,410 		3,000 +407.6% 5.47 US$16,410
2020-10-01 2020-08-21 S Sale
3.1
Biodyne Holding, S.A.
75,000 -5.1%
0.38
US$28,500 		75,000 -5.1% 0.38 US$28,500
2020-10-01 2020-08-20 S Sale
3.1
Biodyne Holding, S.A.
75,000 -4.8%
0.27
US$20,250 		75,000 -4.8% 0.27 US$20,250
2020-10-01 2020-08-19 S Sale
3.1
Biodyne Holding, S.A.
50,000 -3.1%
0.30
US$15,000 		50,000 -3.1% 0.30 US$15,000
2020-10-01 2020-08-18 S Sale
3.1
Biodyne Holding, S.A.
50,000 -3.0%
0.34
US$17,000 		50,000 -3.0% 0.34 US$17,000
2020-10-01 2020-08-14 S Sale
3.1
Biodyne Holding, S.A.
50,000 -2.9%
0.31
US$15,500 		50,000 -2.9% 0.31 US$15,500
2020-10-01 2020-08-03 S Sale
3.1
Biodyne Holding, S.A.
70,000 -3.9%
0.32
US$22,400 		70,000 -3.9% 0.32 US$22,400
2020-10-01 2020-07-31 S Sale
3.1
Biodyne Holding, S.A.
5,000 -0.3%
0.34
US$1,700 		5,000 -0.3% 0.34 US$1,700
2020-10-01 2020-07-30 S Sale
3.1
Biodyne Holding, S.A.
25,000 -1.4%
0.32
US$8,000 		25,000 -1.4% 0.32 US$8,000
2020-10-01 2020-07-21 S Sale
3.1
Biodyne Holding, S.A.
50,000 -2.7%
0.45
US$22,500 		50,000 -2.7% 0.45 US$22,500
2020-10-01 2020-07-20 S Sale
3.1
Biodyne Holding, S.A.
150,000 -7.5%
0.43
US$64,500 		150,000 -7.5% 0.43 US$64,500
2020-10-01 2020-07-17 S Sale
3.1
Biodyne Holding, S.A.
50,000 -2.4%
0.38
US$19,000 		50,000 -2.4% 0.38 US$19,000
2020-10-01 2020-07-16 S Sale
3.1
Biodyne Holding, S.A.
50,000 -2.4%
0.38
US$19,000 		50,000 -2.4% 0.38 US$19,000
2020-10-01 2020-07-06 S Sale
3.1
Biodyne Holding, S.A.
6,450 -0.3%
0.39
US$2,516 		6,450 -0.3% 0.39 US$2,516
2020-10-01 2020-07-02 S Sale
3.1
Biodyne Holding, S.A.
57,000 -2.6%
0.40
US$22,800 		57,000 -2.6% 0.40 US$22,800
2020-10-01 2020-07-01 S Sale
3.1
Biodyne Holding, S.A.
45,000 -2.0%
0.38
US$17,100 		45,000 -2.0% 0.38 US$17,100
2020-10-01 2020-06-29 S Sale
3.1
Biodyne Holding, S.A.
68,094 -3.0%
0.39
US$26,557 		68,094 -3.0% 0.39 US$26,557
2020-10-01 2020-06-26 S Sale
3.1
Biodyne Holding, S.A.
80,000 -3.4%
0.38
US$30,400 		80,000 -3.4% 0.38 US$30,400
2020-10-01 2020-06-25 S Sale
3.1
Biodyne Holding, S.A.
100,000 -4.1%
0.40
US$40,000 		100,000 -4.1% 0.40 US$40,000
2020-10-01 2020-06-24 S Sale
3.1
Biodyne Holding, S.A.
55,530 -2.2%
0.42
US$23,323 		55,530 -2.2% 0.42 US$23,323
2020-10-01 2020-06-23 S Sale
3.1
Biodyne Holding, S.A.
80,000 -3.1%
0.43
US$34,400 		80,000 -3.1% 0.43 US$34,400
2020-10-01 2020-06-22 S Sale
3.1
Biodyne Holding, S.A.
63,186 -2.4%
0.46
US$29,066 		63,186 -2.4% 0.46 US$29,066
2020-10-01 2020-06-19 S Sale
3.1
Biodyne Holding, S.A.
80,000 -2.9%
0.46
US$36,800 		80,000 -2.9% 0.46 US$36,800
2020-10-01 2020-06-18 S Sale
3.1
Biodyne Holding, S.A.
61,640 -2.2%
0.45
US$27,738 		61,640 -2.2% 0.45 US$27,738
2020-10-01 2020-06-17 S Sale
3.1
Biodyne Holding, S.A.
203,100 -6.8%
0.48
US$97,488 		203,100 -6.8% 0.48 US$97,488
2020-10-01 2020-06-16 S Sale
3.1
Biodyne Holding, S.A.
150,000 -4.8%
0.43
US$64,500 		150,000 -4.8% 0.43 US$64,500
2020-10-01 2020-06-15 S Sale
3.1
Biodyne Holding, S.A.
100,000 -3.1%
0.42
US$42,000 		100,000 -3.1% 0.42 US$42,000
2020-10-01 2020-06-11 S Sale
3.1
Biodyne Holding, S.A.
100,000 -3.0%
0.39
US$39,000 		100,000 -3.0% 0.39 US$39,000
2020-06-08 2020-06-03 S Sale
3.1
Biodyne Holding, S.A.
Large shareholder
1,683 -0.1%
0.31
US$522 		1,683 -0.1% 0.31 US$522
2020-06-08 2020-06-03 S Sale
3.1
Biodyne Holding, S.A.
Large shareholder
3,900 -0.1%
0.31
US$1,209 		3,900 -0.1% 0.31 US$1,209
2020-06-08 2020-06-02 S Sale
3.1
Biodyne Holding, S.A.
Large shareholder
220,000 -6.1%
0.33
US$72,600 		220,000 -6.1% 0.33 US$72,600
2020-05-14 2019-06-07 S Sale
3.1
Biodyne Holding, S.A.
Large shareholder
684,813 -16.1%
0.67
US$458,825 		684,813 -16.1% 0.67 US$458,825
2019-03-14 2019-03-12 B Purchase
3.3
BERMAN ROBERT ANDREW

Chief Executive Officer

Executive Director
21,740 +inf%
1.15
US$25,001 		21,740 +inf% 1.15 US$25,001
Explore more

More insider trading research around enVVeno Medical Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America